Therapeutic Efficacy of 29 Antimicrobial Regimens in Experimental Intraabdominal Sepsis
|
|
- Everett Bryant
- 5 years ago
- Views:
Transcription
1 REVEWS OF NFECTOUS DSEASES. VOL. 3, NO.3. MAY-JUNE by The University of Chicago /81/ $02.00 Therapeutic Efficacy of 29 Antimicrobial Regimens in Experimental ntraabdominal Sepsis John G. Bartlett, Thomas J. Louie, Sherwood L. Gorbach, and Andrew B. Onderdonk From the nfectious Disease Research Laboratory, Veterans Administration Hospital, and the Department of Medicine, Tufts University School of Medicine, Boston, Massachusetts An animal model of colonic perforation was used to examine the efficacy of 29 antimicrobial regimens in the treatment of intraabdominal sepsis. Efficacy was judged on mortality during the first 12 days after challenge and on the incidence of intraabdominal abscess noted at necropsy upon completion of the experiment. n general, antimicrobial agents that are active against coliform bacteria prevented early mortality, whereas drugs that are active against Bacteroidesfragilis were most effective in reducing the incidence of late abscess formation. Exceptions were metronidazole, which produced a significant reduction in early mortality, and chloramphenicol, which caused only a modest reduction in the incidence of abscess. Optimal results were obtained with several regimens that showed good in vitro activity against both coliforms and B. fragilis. ntraabdominal infections often involve a complex microflora composed of both aerobic and anaerobic bacteria [1]. The virtual impossibility of differentiating pathogens, commensals, and symbionts in these mixed infections poses a major dilemma. Such distinctions have important implications for our understanding of the pathophysiology of mixed infections, and these distinctions are critical for a rational approach to selection of antimicrobial agents. n an effort to simulate sepsis following colonic perforation, we have developed an animal model of intraabdominal sepsis by use of an intraperitoneal challenge with pooled cecal contents. Our initial studies with this model indicated a twostage disease. At first, we observed acute peritonitis, coliform bacteremia, and a 35%-450/0 mortality. All animals that survived the early acute peritonitis developed the second stage of the disease, which was characterized by formation of intraabdominal abscesses at five to seven days after Received for publication September 16, 1980, and in revised form November 20, This study was supported by grants from The Upjohn Company; Pfizer Laboratories; Eli Lilly and Company; Smith, Kline & French; Merck Sharp & Dohme; Schering; Bristol Laboratories; Hoechst-Roussel Pharmaceuticals; and Hoffmann-LaRoche. Please address requests for reprints to Dr. John Bartlett, Division of nfectious Diseases, The John Hopkins Hospital, Baltimore, Maryland 212Q5. challenge [2]. Bacteriologic studies have shown that Escherichia coli is the numerically dominant organism in exudate obtained during the early, peritonitis stage, whereas Bacteroides fragilis is the numerically dominant microbe in the contents of abscesses [3]. n subsequent experiments inocula composed of various bacterial species in pure culture were used in place of the mixed fecal flora. The results showed that E. coli caused early lethality, and B. fragilis appeared to be responsible for formation of intraabdominal abscesses [4, 5]. Our conclusions regarding the role of coliform bacteria and anaerobes in this animal model were further supported with antimicrobial trials [6]. We noted that gentamicin protected against lethality, but had no effect on the incidence of intraabdominal abscess; by contrast, clindamycin failed to alter mortality, but produced a significant reduction in the incidence of abscess. The initial selection of antimicrobial agents for testing in this model was based on the restricted spectra of activity of gentamicin and clindamycin. These agents permitted comparison of results of treatment directed against coliforms and treatment directed against anaerobes. However, numerous other antimicrobial agents and combinations of agents are commonly used for patients with intraabdominal sepsis. The present study is a comparative trial of 29 chemotherapeutic regimens in this model. Results with 12 of these regimens 535
2 536 Bartlett et al. have been reported previously and are included here for comparison [6-10]. Materials and Methods Animal Model. Details of this animal model and the natural course of the disease have been summarized previously [2, 3]. Briefly, male Wistar rats (Charles River Breeding Laboratories, Wilmington, Mass.) weighing g were used for all experiments. The inoculum was prepared in an anaerobic chamber by use of techniques designed to insure a uniform challenge to all recipients. Cecal contents from meat-fed rats were pooled and then mixed with an equal volume of prereduced peptone yeast glucose broth and sterile barium sulfate (10070 wt/vol), The pooled inoculum was filtered through surgical gauze, placed into 5-ml vials, quick-frozen in liquid nitrogen, and then stored at - 40 C until used. Previous studies indicated that the concentrations of bacterial species of this inoculum did not change after prolonged periods of storage in a frozen state [3]. At the time of challenge, the frozen inoculum was thawed in an anaerobic chamber. Aliquots of 0.5 ml were placed into sterile gelatin capsules for intraperitoneal insertion, by midline abdominal incision, into rats. Antimicrobial agents. Seventeen antimicrobial agents were tested either alone or in various combinations. These agents were clindamycin (The Upjohn Company, Kalamazoo, Mich.), chloramphenicol (Parke, Davis & Company, Detroit, Mich.), doxycycline (Pfizer Laboratories, New York, N.Y.), penicillin G (Squibb & Sons, Princeton, N.J.), carbenicillin (Pfizer Laboratories), rosamicin (Rosaramicin'P; Schering, Kenilworth, N.J.), metronidazole (Searle & Co., Chicago, ll.), cephalothin (Eli Lilly and Company, ndianapolis, nd.) moxalactam (Eli Lilly and Company), cefazolin (Smith Kline & French, Philadelphia, Pa.), cefoxitin (Merck Sharp & Dohme, West Point, Pa.), gentamicin (Schering), amikacin (Bristol Laboratories, Syracuse, N. Y.), tobramycin (Eli Lilly and Company), spectinomycin (The Upjohn Company), erythromycin (Abbott Laboratories, Chicago, ll.), cefotaxime (Hoechst-Roussel Pharmaceuticals, Somerville, N.J.), and sulfamethoxazole-trimethoprim (Hoffmann-LaRoche, Nutley, N. J.). Antimicrobial dosage. Antimicrobial dosage was selected according to levels of drug in the serum of healthy Wistar rats after administration of arbitrarily selected doses. n most instances, this approximated the usual recommended dose for patients in mg/kg multiplied by six to adjust for the body surface area of a 160- to 180-g animal [11]. The antimicrobial agents were given im to a minimum of five healthy control animals, and serum was obtained by cardiac puncture at intervals of 0.5, 1, 4, and 8 hr. Levels of drug in serum were measured by agar diffusion assay with Bacillus subtilis ATCC (American Type Culture Collection, Rockville, Md.) no as the test organism [12], or by the hemolysis inhibition assay with Clostridium perfringens Boston Veterans Administration strain no. 249 as the test organism [13]. Levels of trimethoprim were determined by spectrophotometry [14]. Susceptibility to antimicrobial agents. n vitro susceptibility of strains of three bacterial species to the antimicrobial agents was tested. E. coli, Streptococcus faecalis, and B. fragilis were selected because, in terms of both frequency of recovery and numerical concentration, they were the predominant isolates recovered from infected sites of untreated animals [3]. By use of microtiter techniques, susceptibility tests were done with serial twofold dilutions of the antimicrobial agents [15]. E. coli and S. faecalis were grown in Mueller Hinton broth with an inoculum of cfu/ml and incubated in air. B. fragilis was tested using an inoculum of cfu/ml after growth in prereduced brain-heart infusion supplemented broth (Scott Laboratories, Fiskeville, R..). MCs were defined as the lowest concentrations giving no visible growth after a 24-hr incubation period for aerobes and after incubation for 48 hr in an anaerobic chamber for anaerobes. Treatment. The experiments were conducted sequentially using groups of animals tested simultaneously. Each experimental group included rats given an antimicrobial regimen and untreated control animals. All antimicrobial agents were given by im injection. Treatment was initiated 4 hr after implantation and then was given at 8-hr intervals for 10 days. An exception was carbenicillin, which was given at 4-hr intervals. Evaluation of treatment. Results of antimi-
3 Regimensfor ntraabdominal Sepsis 537 crobial treatment were evaluated by two criteria: mortality and incidence of intraabdominal abscesses. Mortality was determined by the number of animals that expired within 12 days after implantation. All surviving animals were sacrificed at 12 days for necropsy to detect intra-abdominal abscesses. The criterion for abscess was a loculated, grossly purulent collection that demonstrated numerous polymorphonuclear cells and bacteria by direct gram stain. Animals were considered cured if they had survived the duration of the experiments and if necropsy revealed no intraabdominal abscesses. Treatment groups were compared with a normal approximation technique using the binomial distribution with confidence intervals [16]. Results Levels ojdrug in serum. Peak levels of drug in serum obtained with the antimicrobial test agents are summarized in table 1. The values given represent the mean levels obtained with doses used in Table 1. Antimicrobial doses and levels of drug in serum of rats. Mean level of drug in serum" at Antimicrobial Dose agent (mg) 0.5 hr 1 hr 4 hr 8 hr Amikacin 7 NT 40 NT 2 Gentamicin 2 NT 6.9 NT <0.5 Tobramycin 2 NT 7.1 NT <0.5 Cephalothin <0.5 Cephalothin <0.5 Cefazoiin <0.5 Cefazolin <0.5 Cefamandole <0.5 Cefamandole <0.5 Cefoxitin <0.5 Cefotaxime <0.5 Moxalactam <0.5 Penicillin G <0.5 Carbenicillin <0.5 Doxycycline 4 NT <0.5 Chloramphenicol <0.5 Ciindamycin NT <0.5 Rosamicin <0.1 Erythromycin <0.5 Metronidazole Trimethoprim <0.5 NOTE. NT = not tested. * Mean level of drug io serum in Ag/ml with ~5 healthy animals for each determination. subsequent experiments to compare efficacy. Two dose regimens were tested with cephalothin, cefazolin, and cefamandole because of the wide variations in dose recommendations for these agents in clinical practice. Sera obtained at 4 hr showed detectable levels ofall drugs except cephalothin (low-dose regimen), chloramphenicol, and rosamicin. Sera obtained at 8 hr showed no detectable bioactivity with any drug except for low levels with doxycycline, metronidazole, and amikacin. Subsequent testing of these agents after five doses at 8-hr intervals showed evidence of accumulation of doxycycline only, with a mean peak level of 4.2 ~g/ml and a mean trough level of 2.2 ug/ml. n vitro susceptibility. n vitro susceptibility tests showed E. coli to be susceptible to readily achieved levels of aminoglycosides, cephalosporins, cefoxitin, moxalactam, carbenicillin, doxycycline, and chloramphenicol (table 2). As anticipated, the strain of S. jaeca/is proved resistant to most agents tested. B. jragilis was sensitive to clindamycin, cefoxitin, cefotaxime, moxalactam, chloramphenicol, rosamicin, erythromycin, and metronidazole. Susceptibility was not tested for sulfamethoxazole-trimethoprim. Table 2. n vitro susceptibility of three organisms to antimicrobial drugs. Susceptibility of indicated organisms Antimicrobial Escherichia Streptococcus Bacteroides agent coli faecalis fragilis Amikacin 2 >128 >128 Gentamicin 0.1 >32 >32 Tobramycin 0.1 >32 >32 Spectinomycin Cephalothin Cefazolin Cefamando1e Cefoxitin 4 >64 8 Cefotaxime 2 >64 8 Moxalactam 1 >64 2 Penicillin G Carbenicillin Doxycycline Chloramphenicol Clindamycin >64 > Rosamicin Erythromycin > Metronidazole >256 NT 4 NOTE. NT = not tested. Minimum inhibitory concentration in Ag/mt.
4 538 Bartlett et al. Results of antimicrobial treatment. The comparative efficacy of the 29 antimicrobial regimens tested in the rat model is summarized in table 3. With all regimens except clindamycin, mortality of treated animals was significantly less than that of untreated controls. Mortality with regimens that included an aminoglycoside was (24 of 425 animals); with cephalosporins it was 7.60/0 (29 of 379 animals). Mortality was comparable with penicillin, spectinomycin, chloramphenicol, metroni- dazole, and sulfamethoxazole-trimethoprim. With all these regimens, the reduction in mortality was significant when compared with untreated controls. The incidence of intraabdominal abscess noted at necropsy in animals that survived for 12 days after implantation showed considerable variation. Optimal results were obtained with clindamycin, cefoxitin, clindamycin plus gentamicin, cefotaxime, moxalactam, rosamicin plus gentamicin, cefamandole plus erythromycin, and carbenicillin Table 3. Results of treatment with antimicrobial agents for rats with intraabdominal sepsis. No. of animals No. of animals No. of animals that died/total no. of with abscesses/no. of cured/total no. of Treatment group animals in group (070) surviving animals (070) animals in group (070) Untreated controls 108/295 (37) 187/187 (100) 0/295 Gentamicin 2157 (4) 54/55 (98) 1/57 (2) Amikacin 2130 (7) 27/28 (96) 1/30 (3) Penicillin 4/30 (13) 24/26 (92) 2/30 (7) Sulfamethoxazoletrimethoprim 0/30 23/30 (77) 7/30 (23) Penicillin plus amikacin 0/30 22/30 (73) 8/30 (27) Chloramphenicol 2/60 (3) 34/58 (59) 24/60 (40) Cefazolin (L)* 2/30 (7) 14/28 (50) 14/30 (47) Cefamandole (L) plus tobramycin 4/30 (13) 10/26 (38) 16/30 (54) Doxycycline 7/30 (23) 7/23 (30) 16/30 (54) Clindamycin 37/89 (42) 3/53 (6) 49/89 (55) Cefamandole (L) 4/30 (13) 9/26 (35) 17/30 (57) Cephalothin (L) 1/30 (3) 11/29 (38) 18/30 (60) Erythromycin 16/60 (27) 6/44 (14) 38/60 (63) Carbenicillin 11/60 (18) 7/49 (14) 42/60 (70) Cefazolin (H) t 0/30 8/30 (27) 22/30 (73) Cefamandole (H) 1/30 (3) 7/29 (24) 22/30 (73) Cephalothin (H) 8/50 (16) 4/42 (10) 38/50 (76) Metronidazole 5/50 (10) 6/45 (13) 39/50 (78) Doxycycline plus gentamicin 2130 (7) 4/28 (14) 24/30 (80) Cefamandole (L) plus erythromycin 7/60 (12) 2/53 (4) 51/60 (85) Rosamicin plus gentamicin 2130 (7) 2/28 (7) 26/30 (87) Spectinomycin 1/52 (2) 6/51 (12) 45/52 (87) Clindamycin plus gentamicin 10/158 (7) 6/148 (5) (90) Carbenicillin plus gentamicin 2160 (3) 4/58 (7) 54/60 (90) Moxalactam (L) 2/59 (3) 4/57 (7) 53/59 (90) Cefoxitin (L) 0/30 2/30 (7) 28/30 (93) Cefotaxime (L) 1/29 (3) 1/28 (4) 27/29 (93) Spectinomycin plus clindamycin 0/25 1/25 (4) 24/25 (96) Cefamandole (H) plus erythromycin 1/30 (3) /30 (97) * L = low dose regimen (20 mg). t H = high dose regimen (55 mg).
5 Regimens/or lntraabdominal Sepsis 539 plus gentarmcm. The incidence of abscess in surviving animals treated with these regimens varied from 0 to 7010, and there was no statistically significant difference between regimens (figure 1). Animals treated with cephalothin, cefazolin, cefamandole, and cefamandole plus tobramycin showed abscess rates of with the higher rates in the low-dose regimens; an exception was the group given a high dose of cephalothin, in which abscesses were noted in only of surviving animals. The incidence of abscess with chloramphenicol- 59% - was significantly lower than that of untreated controls but higher than that found in 18 of the 28 other treatment regimens. Overall efficacy of the regimens was evaluated on the basis of cure rates (figure 2). Superior single-agent regimens in this assessment were cefoxitin, cefotaxime, moxalactam, and spectinomycin. Comparable results were noted with erythromycin plus cefamandole and with each of the following when combined with gentamicin: carbenicillin, clindamycin, rosamicin, and doxycycline. Cure rates for these treatment groups ranged from to 97010, and there was no statistically significant difference between them. Treatment with cephalosporins was somewhat inferior primarily because of an increased incidence of intraabdominal abscess. The least effective regimens were aminoglycosides alone, penicillin, sulfamethoxazole-trimethoprim, chloramphenicol, and penicillin combined with amikacin, primarily because of the increased incidence of intraabdominal abscess. Discussion Animal models have been used extensively to study in vivo response to antimicrobial agents. n order for such models to have clinical application, they must simulate disease processes encountered in patients. Our previous studies with this model of intraabdominal sepsis indicate that several important criteria have been fulfilled. Bacteriologic studies of the inoculum show it to be similar to the fecal flora of humans. Also, the sequence of pathologic events simulates the septic complications often seen after colonic perforation in patients. Additionally, the bacteriology of the infection and the susceptibility profiles of these microbes are similar "to those reported in clinical studies of intraabdominal sepsis. <;efamandole (Hl+ Erythromycin Cefotaxime ~ Cefamardoleru "Erythromycin Ci~damlcin+SpeCtinOmYCin ~lin.dam~cin+ Gentam icin Clindam~cin Cefoxitin Moxalactam ---4 Carbenicillin+ Gentamicin ---4 Rosa~amicln+Gentamic in Cephalothin (H) Srctin:>mYCir Metronidazole Erlythro~ycin Doxycycline+Gentamicin Carbenicillin Cef;mandol1e (H Cefazolin(H DOxycy~line Cefe mandole u) CePh:lothin (Ll CTfamandole (L)+Tobramycin Cefazo~in (Ll Chloramphenicol peniciain+ Amikacin J Sui arethoxazol:-t rimethopr ir Pe~icillin Amikacin...- Gentamicin... o ~o ~o % Of Surviving AnimalsWith Abscesses Figure 1. ncidence of intraabdominal abscess in surviving rats when sacrificed 12 days after intraperitoneal challenge with pooled cecal contents. Point indicates percent with abscesses; bar indicates 950,10 confidence interval constructed around portions using a normal approximation technique. Most animal models of therapeutic efficacy utilize a challenge of a single microbe in pure culture. n general, correlation between in vitro susceptibility and in vivo response has been good. ntraabdominal sepsis, however, poses far more complex questions because there are multiple bacterial species in both the inoculum and at infected sites. The problem is to determine which microbes are true pathogens and therefore require specific treatment. Because of variables in the hosts, differences in disease processes, lack of untreated controls, and the often critical role of surgical intervention, clinical trials have not provided definitive answers to these questions. These considerations make the animal model of intraabdominal sepsis particularly appropriate. Our previous studies suggested that primarily coliforms were responsible for early lethality in this model. The present study showed that, except
6 540 Bartlett et al. Erythromycin Cephal~thin (L) Cefamandole (L) Clindamyci n Doxyc~cline Crfamandole ~L)+TobramYCir Cef a:olin (L) Chloramphenicol Penicillin+ Art i kacin Sulfamethoxazole-trimethoprim Penicillin A~ j1kafin G~amicin Cefamandole (H)+Erythromycin ClindamylmtlpFctinomycin Cefotaxime Cefoxitin Moxalactam Carbeni~iin+- ~entaticin Clindamyclin+~entamicin Spectinomycin Rosaramicin +-Gentamic i n Cefamandole(L) +-Erythromycin Doxycycline +- Gentamicin Metronidazole qephalo~hin (H) Cefamandole (H) Cefazolin (H),, o % Cured for clindamycin, all antimicrobial regimens tested produced a significant reduction in mortality compared with untreated control animals. Mortality with regimens that included an aminoglycoside or a cephalosporin was only %; mortality of untreated controls was Penicillin G also reduced mortality, but this result might be explained by the use of large doses, which resulted in peak serum levels of drug well in excess of the MC for E. coli. More difficult to explain, however, is the reduced mortality achieved with metronidazole. Only of the animals that received this drug expired, despite its poor in vitro activity against E. coli. This observation is of interest in view of clinical trials showing that metronidazole treatment of mixed aerobic-anaerobic infections resulted in eradication of resistant coliforms as well as susceptible anaerobes from the infected site [17]. More extensive studies with this model showed that treatment with metronidazole reduces the Figure 2. Cure rate, indicating survival without evidence of intraabdominal abscesses, in rats sacrificed 12 days after intraperitoneal challenge with pooled cecal contents. Point refers to percent cured and bar indicates confidence limits. incidence of bacteremia due to E. coli, but this effect is noted only when susceptible anaerobic bacteria are included in the inoculum [8]. Similar results were noted with mixed cultures in vitro. A conclusion from this experiment was that anaerobic bacteria may convert metronidazole to metabolites that are active against the coliforms. The major differences between regimens were seen with the incidence ofintraabdominal abscess. n general, there was a good correlation between prevention of abscess and in vitro activity of the antimicrobial test agent vs. B. fragilis. The overall incidence of abscess with aminoglycoside treatment alone was 98070; with three cephalosporin regimens (cephalothin, cefamandole, and cefazolin) it was Among these three cephalosporins, cephalothin appeared somewhat superior, possibly because of its relatively greater resistance to the fj-actamase of B. fragilis. The lowest incidence of abscess was noted with clindamycin,
7 Regimensjor ntraabdominal Sepsis 541 erythromycin, carbenicillin, metronidazole, rosamicin, high-dose cephalothin, spectinomycin, cefotaxime, cefoxitin, and moxalactam. All these drugs, with the exception of cephalothin, showed good in vitro activity against the strain of B. fragilis employed in the inoculum. Regimens using these drugs alone or in combination with an aminoglycoside showed abscess rates of 0 to only A discrepancy was noted between activity in vitro and results in vivo with chloramphenicol treatment vs. B. fragilis. The incidence of abscess in chloramphenicol recipients was 59% despite a mean peak level of drug in serum of 22 ug/rnl, which is well in excess of the MC for B. fragilis. A possible explanation for this discrepancy between in vitro and in vivo response is that anaerobes may inactivate chloramphenicol by enzymatic reduction of the nitro group [9]. Because the process of inactivation is slow, the organisms appear susceptible according to the usual in vitro susceptibility tests. The clinical relevance of these observations is uncertain. Two agents of special interest were spectinomycin and sulfamethoxazole-trimethoprim, since previous studies have shown divergent results, which appear to reflect differences in assay methodology, with in vitro testing vs. B. fragilis [18-21]. The results obtained in the present experiments showed good in vivo activity against this organism for spectinomycin and relatively poor activity for sulfamethoxazole-trimethoprim. The conclusion of this study, in which multiple antimicrobial agents were tested in experimental intraabdominal sepsis, is that optimal results were obtained with drug regimens that were active against both coliforms and anaerobes. Enterococci did not appear to play an important role in this model despite their frequent presence in the mixed flora found at infected sites. This conclusion is based on the observation that treatment directed against enterococci, such as penicillin combined with an aminoglycoside, showed minimal difference compared with results with either penicillin or an aminoglycoside alone. Furthermore, our previous studies using inocula of various bacteria in pure culture have shown that enterococci failed to cause bacteremia, mortality, or abscesses in the rat model [4]. This point is emphasized because the necessity of selecting antimicrobial agents active against enterococci is a frequent topic of debate in the management of intraabdominal sepsis. Certain limitations in this study should be noted. First, the inoculum was composed of pooled cecal contents to insure that each animal received an identical challenge. However, a disadvantage of this experimental design is that conclusions are restricted to a limited number of microbial strains. Variations from our results might be anticipated with the use of inocula composed of other bacterial species or strains with different in vitro susceptibility profiles. Another limitation is that the experiment was standardized so that untreated animals had a mortality of 35%-45%, and all surviving animals had intraabdominal abscesses. Using a similar model, Nichols et al. [22] have shown results whose variation from ours depend largely on inoculum size. t is obvious that our model represents just one form in a spectrum of diseases associated with colonic perforation. Finally, antimicrobial treatment was initiated 4 hr after challenge. This time was arbitrarily selected because it proved sufficiently early to produce a therapeutic response, yet sufficiently delayed to simulate the realities of clinical practice. Our subsequent studies have shown that treatment of animals with clindamycin after abscesses have formed provides no apparent benefit (authors' unpublished observations). This indicates that the outcome may be quite different when antimicrobial treatment is initiated at a later time in the evolution of the infection. References 1. Thadepalli, H., Gorbach, S. L., Broido, P. W., Norsen, J., Nyhus, L. M. Abdominal trauma, anaerobes and antibiotics. Surg. Gynecol. Obstet. 137: , Weinstein, W. M., Onderdonk, A. B., Bartlett, J. G., Gorbach, S. L. Experimental intra-abdominal abscesses in rats: development of an experimental model. nfect. mmun. 10: , Onderdonk, A. B., Weinstein, W. M., Sullivan, N. M., Bartlett, J. G., Gorbach, S. L. Experimental intraabdominal abscesses in rats: quantitative bacteriologyof infected animals. nfect. mmun. 10: , Onderdonk, A. B., Bartlett, J. G., Louie, T., Sullivan Seigler, N., Gorbach, S. L. Microbial synergy in experimental intra-abdominal abscess. nfect. mmun. 13: 22-26, Onderdonk, A. B., Kasper, D. L., Cisneros, R. L., Bartlett, J. G. The capsular polysaccharide of Bacteroides jragilis as a virulence factor: comparison of the pathogenic potential of encapsulated and unencapsulated strains. J. nfect. Dis. 136:82-89, Weinstein, W. M., Onderdonk, A. B., Bartlett, J. G.,
8 542 Bartlett et al. Louie, T. J., Gorbach, S. L. Antimicrobial therapy of experimental intraabdominal sepsis. J. nfect. Dis. 132: , Bartlett, J. G., Onderdonk, A. B., Louie, T. J., Kasper, D. L., Gorbach, S. L. Lessons from an animal model of intra-abdominal sepsis. Arch. Surg. 113: , Onderdonk, A. B., Louie, T. J., Tally, F. P., Bartlett, J. G. Activity of metronidazole against Escherichia coli in experimental intra-abdominal sepsis. J. Antimicrob. Chemother. 5: , Onderdonk, A. B., Kasper, D. L., Mansheim, B. J., Louie, T. J., Gorbach, S. L., Bartlett, J. G. Experimental animal models for anaerobic infections. Rev. nfect. Dis. 1: , Louie, T. J., Onderdonk, A. B., Gorbach, S. L., Bartlett, J. G. Therapy for experimental intraabdominal sepsis: comparison of four cephalosporins with c1indamycin plus gentamicin. J. nfect. Dis. 135(Suppl.):S8-S22, Freireich, E. J., Gehan, E. A., Rail, D. P., Schmidt, L. H., Skipper, H. E. Quantitative comparison of toxicity of anticancer agents in mouse, rat, hamster, dog, monkey, and man. Cancer Chemotherapy Reports 50: , Sabath, L. D. A simple, rapid microassay for nephrotoxic antibiotics. Scope Monograph, The Upjohn Co., Kalamazoo, Mich., 1972, p Louie, T. J., Tally, F. P., Bartlett, J. G., Gorbach, S. L. Rapid microbiological assay for chloramphenicol and tetracyclines. Antimicrob. Agents Chemother. 9: , Schwartz, D. E., Koechlin, B. A., Weinfeld, R. E. Spectrofluorimetric method for the determination of trimethoprim in body fluids. Chemother 14(Suppl.): 22-29, Rotile, C. A., Fass, R. J., Prior, R. B., Perkins, R. L. Microdilution technique for antimicrobial susceptibility testing of anaerobic bacteria. Antimicrob. Agents Chemother. 7: , Colton, T. Statistics in Medicine. Little, Brown, and Co., Boston, 1974, p Eykyn, S. J., Phillips,. Metronidazole in surgical infections. J. Antimicrob. Chemother. 4(Suppl. C):75-81, Rosenblatt, J. E., Gerdts, A. M. Activity of spectinomycin against anaerobes. Antimicrob. Agents Chemother. 12:37-39, Phillips, 1., Warren, C. Susceptibility of Bacteroides fragilis to spectinomycin. J. Antimicrob. Chemother. : 91-95, Rosenblatt, J. E., Stewart, P. R. Lack of activity of sulfamethoxazole and trimethoprim against anaerobic bacteria. Antimicrob. Agents Chemother. 6:93-97, Phillips, 1., Warren, C. Activity of sulfamethoxazole and trimethoprim against Bacteroides fragilis. Antimicrob. Agents Chemother. 9: , Nichols, R. L., Smith, J. W., Fossedal, E. N., Condon, R. E. Efficacy of parenteral antibiotics in the treatment of experimentally induced intraabdominal sepsis. Rev. nfect. Dis. 1: , 1979.
.'URRENT THERAPEUTIC RESEA. VOLUME 66, NUMBER 3, MAY/JuNE 2005
.'URRENT THERAPEUTIC RESEA VOLUME 66, NUMBER 3, MAY/JuNE 2005 Efficacy of Moxifloxacin Monotherapy Versus Gatifloxacin Monotherapy, Piperacillin- Tazobactam Combination Therapy, and Clindamycin Plus Gentamicin
More informationEffects of Minocycline and Other Antibiotics on Fusobacterium necrophorum Infections in Mice
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Apr. 1975, p. 421-425 Copyright 0 1975 American Society for Microbiology Vol. 7, No. 4 Printed in U.S.A. Effects of Minocycline and Other s on Fusobacterium necrophorum
More informationRisk of Infection Following Penetrating Abdominal Trauma: A Selective Review
THE YALE JOURNAL OF BIOLOGY AND MEDICINE 59 (1986), 395-401 Risk of Infection Following Penetrating Abdominal Trauma: A Selective Review DANIEL SCOTT RUSH, M.D., AND RONALD LEE NICHOLS, M.D. Department
More informationVOL. XXIII NO. II THE JOURNAL OF ANTIBIOTICS 559. ANTIBIOTIC 6640.* Ill
VOL. XXIII NO. II THE JOURNAL OF ANTIBIOTICS 559 ANTIBIOTIC 6640.* Ill BIOLOGICAL STUDIES WITH ANTIBIOTIC 6640, A NEW BROAD-SPECTRUM AMINOGLYCOSIDE ANTIBIOTIC J. Allan Waitz, Eugene L. Moss, Jr., Edwin
More information2 0 hr. 2 hr. 4 hr. 8 hr. 10 hr. 12 hr.14 hr. 16 hr. 18 hr. 20 hr. 22 hr. 24 hr. (time)
Key words I μ μ μ μ μ μ μ μ μ μ μ μ μ μ II Fig. 1. Microdilution plate. The dilution step of the antimicrobial agent is prepared in the -well microplate. Serial twofold dilution were prepared according
More informationECOLOGICAL IMPACT OF NARROW SPECTRUM ANTIMICROBIAL AGENTS COMPARED TO BROAD SPECTRUM AGENTS ON THE HUMAN INTESTINAL MICROFLORA CARL ERIK NORD
Old Herborn University Seminar Monograph 3: Consequences of antimicrobial therapy for the composition of the microflora of the digestive tract. Editors: Carl Erik Nord, Peter J. Heidt, Volker Rusch, and
More informationSynergism Between Penicillin, Clindamycin, or Metronidazole and Gentamicin Against Species of the Bacteroides melaninogenicus and
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Jan. 1984, p. 71-77 0066-4804/84/010071-07$02.00/0 Copyright C 1984, American Society for Microbiology Vol. 25, No. 1 Synergism Between Penicillin, Clindamycin, or
More informationGive the Right Antibiotics in Trauma Mitchell J Daley, PharmD, BCPS
Give the Right Antibiotics in Trauma Mitchell J Daley, PharmD, BCPS Clinical Pharmacy Specialist, Critical Care Dell Seton Medical Center at the University of Texas and Seton Healthcare Family Clinical
More informationIntroduction to Pharmacokinetics and Pharmacodynamics
Introduction to Pharmacokinetics and Pharmacodynamics Diane M. Cappelletty, Pharm.D. Assistant Professor of Pharmacy Practice Wayne State University August, 2001 Vocabulary Clearance Renal elimination:
More informationMulticenter Study of In Vitro Susceptibility of the Bacteroides fragilis Group, 1995 to 1996, with Comparison of Resistance Trends from 1990 to 1996
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Oct. 1999, p. 2417 2422 Vol. 43, No. 10 0066-4804/99/$04.00 0 Copyright 1999, American Society for Microbiology. All Rights Reserved. Multicenter Study of In Vitro
More informationSynergism of penicillin or ampicillin combined with sissomicin or netilmicin against enterococci
Journal of Antimicrobial Chemotherapy (78) 4, 53-543 Synergism of penicillin or ampicillin combined with sissomicin or netilmicin against enterococci Chatrchal Watanakunakoni and Cheryl Glotzbecker Infectious
More informationEvaluation of a computerized antimicrobial susceptibility system with bacteria isolated from animals
J Vet Diagn Invest :164 168 (1998) Evaluation of a computerized antimicrobial susceptibility system with bacteria isolated from animals Susannah K. Hubert, Phouc Dinh Nguyen, Robert D. Walker Abstract.
More informationSecondary peritonitis
Secondary peritonitis Caused by spillage of gastrointestinal microorganisms into the peritoneal cavity secondary to loss of the integrity of the mucosal barriers Etiology: perforation of peptic ulcer traumatic
More informationProphylactic antibiotics in penetrating abdominal trauma: Outcome data
Prophylactic antibiotics in trauma: Outcome data Author & Reference Title Class Antibiotics #Pts Duration (days) Organs injured The duration of Bozorgzedeh A antibiotic administration I cefoxitin 148 24
More informationon February 12, 2018 by guest
AAC Accepted Manuscript Posted Online 12 February 2018 Antimicrob. Agents Chemother. doi:10.1128/aac.00047-18 Copyright 2018 Stapert et al. This is an open-access article distributed under the terms of
More informationagainst Clinical Isolates of Gram-Positive Bacteria
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Feb. 993, p. 366-370 Vol. 37, No. 0066-0/93/00366-05$0.00/0 Copyright 993, American Society for Microbiology In Vitro Activity of CP-99,9, a New Fluoroquinolone,
More informationBrief reports. Heat stability of the antimicrobial activity of sixty-two antibacterial agents
Journal of Antimicrobial Chemotherapy (5) 35, -5 Brief reports Heat stability of the antimicrobial activity of sixty-two antibacterial agents Walter H. Traub and Birgit Leonhard Institut fur Medizinische
More informationPharmacological Evaluation of Amikacin in Neonates
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, JUlY 1975, p. 86-90 Copyright 0 1975 American Society for Microbiology Vol. 8, No. 1 Printed in U.SA. Pharmacological Evaluation of Amikacin in Neonates JORGE B.
More informationScottish Medicines Consortium
Scottish Medicines Consortium tigecycline 50mg vial of powder for intravenous infusion (Tygacil ) (277/06) Wyeth 9 June 2006 The Scottish Medicines Consortium (SMC) has completed its assessment of the
More informationUSA Product Label LINCOCIN. brand of lincomycin hydrochloride tablets. brand of lincomycin hydrochloride injection, USP. For Use in Animals Only
USA Product Label http://www.vetdepot.com PHARMACIA & UPJOHN COMPANY Division of Pfizer Inc. Distributed by PFIZER INC. 235 E. 42ND ST., NEW YORK, NY, 10017 Telephone: 269-833-4000 Fax: 616-833-4077 Customer
More informationProject Summary. Impact of Feeding Neomycin on the Emergence of Antibiotic Resistance in E. coli O157:H7 and Commensal Organisms
Project Summary Impact of Feeding Neomycin on the Emergence of Antibiotic Resistance in E. coli O157:H7 and Commensal Organisms Principal Investigators: Mindy Brashears, Ph.D., Texas Tech University Guy
More informationEvaluation of the BIOGRAM Antimicrobial Susceptibility Test System
JOURNAL OF CLINICAL MICROBIOLOGY, Nov. 1985, p. 793-798 0095-1137/85/110793-06$02.00/0 Copyright 1985, American Society for Microbiology Vol. 22, No. 5 Evaluation of the BIOGRAM Antimicrobial Susceptibility
More informationPerformance Information. Vet use only
Performance Information Vet use only Performance of plates read manually was measured in three sites. Each centre tested Enterobacteriaceae, streptococci, staphylococci and pseudomonas-like organisms.
More informationمادة االدوية المرحلة الثالثة م. غدير حاتم محمد
م. مادة االدوية المرحلة الثالثة م. غدير حاتم محمد 2017-2016 ANTIMICROBIAL DRUGS Antimicrobial drugs Lecture 1 Antimicrobial Drugs Chemotherapy: The use of drugs to treat a disease. Antimicrobial drugs:
More informationa. 379 laboratories provided quantitative results, e.g (DD method) to 35.4% (MIC method) of all participants; see Table 2.
AND QUANTITATIVE PRECISION (SAMPLE UR-01, 2017) Background and Plan of Analysis Sample UR-01 (2017) was sent to API participants as a simulated urine culture for recognition of a significant pathogen colony
More informationComparison of Clindamycin, Erythromycin, and Methicillin in Streptococcal Infections in Monkeys
ANTIbMCROBIAL AGENTS AND CHEMOTHERAPY, June 197, p. 460-465 Copyright 197 American Society for Microbiology Vol. 1, No. 6 Printed in U.S.A. Comparison of Clindamycin, Erythromycin, and Methicillin in Streptococcal
More informationAntimicrobial Pharmacodynamics
Antimicrobial Pharmacodynamics November 28, 2007 George P. Allen, Pharm.D. Assistant Professor, Pharmacy Practice OSU College of Pharmacy at OHSU Objectives Become familiar with PD parameters what they
More informationAn evaluation of the susceptibility patterns of Gram-negative organisms isolated in cancer centres with aminoglycoside usage
Journal of Antimicrobial Chemotherapy (1991) 27, Suppl. C, 1-7 An evaluation of the susceptibility patterns of Gram-negative organisms isolated in cancer centres with aminoglycoside usage J. J. Muscato",
More informationComparative Activity of Netilmicin, Gentamicin, Amikacin, and Tobramycin Against Pseudomonas aeruginosa and Enterobacteriaceae
ANTIMICROBIAL AGzNTS AND CHEMOTHERAPY, Oct. 1976, P. 592-597 Copyright 1976 American Society for Microbiology Vol. 1, No. 4 Printed in U.S.A. Comparative Activity of Netilmicin, Gentamicin, Amikacin, and
More informationTel: Fax:
CONCISE COMMUNICATION Bactericidal activity and synergy studies of BAL,a novel pyrrolidinone--ylidenemethyl cephem,tested against streptococci, enterococci and methicillin-resistant staphylococci L. M.
More informationEffeet on Bacterial Growth
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Nov. 17, p. 36-366 Copyright ( 17 American Society for Microbiology Vol., No. 5 Printed in U.S.A. Automatic Radiometric Measurement of Antibiotic Effeet on Bacterial
More informationJanuary 2014 Vol. 34 No. 1
January 2014 Vol. 34 No. 1. and Minimal Inhibitory Concentration (MIC) Interpretive Standards for Testing Conditions Medium: diffusion: Mueller-Hinton agar (MHA) roth dilution: cation-adjusted Mueller-Hinton
More informationProphylactic antibiotic timing and dosage. Dr. Sanjeev Singh AIMS, Kochi
Prophylactic antibiotic timing and dosage Dr. Sanjeev Singh AIMS, Kochi Meaning - Webster Medical Definition of prophylaxis plural pro phy lax es \-ˈlak-ˌsēz\play : measures designed to preserve health
More informationHelp with moving disc diffusion methods from BSAC to EUCAST. Media BSAC EUCAST
Help with moving disc diffusion methods from BSAC to EUCAST This document sets out the main differences between the BSAC and EUCAST disc diffusion methods with specific emphasis on preparation prior to
More informationJan A. Jacobs* and Ellen E. Stobberingh
Journal of Antimicrobial Chemotherapy (996) 37, 37-375 In-vitro antimicrobial susceptibility of the 'Streptococcus millerv group {Streptococcus anginosus, Streptococcus constellatus and Streptococcus intermedius)
More informationAntimicrobial Susceptibility Testing: The Basics
Antimicrobial Susceptibility Testing: The Basics Susan E. Sharp, Ph.D., DABMM, FAAM Director, Airport Way Regional Laboratory Director, Regional Microbiology and Molecular Infectious Diseases Laboratories
More informationJanuary 2014 Vol. 34 No. 1
January 2014 Vol. 34 No. 1. and Minimum Inhibitory Concentration (MIC) Interpretive Standards for Testing Conditions Medium: diffusion: Mueller-Hinton agar (MHA) Broth dilution: cation-adjusted Mueller-Hinton
More informationMICHAEL J. RYBAK,* ELLIE HERSHBERGER, TABITHA MOLDOVAN, AND RICHARD G. GRUCZ
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Apr. 2000, p. 1062 1066 Vol. 44, No. 4 0066-4804/00/$04.00 0 Copyright 2000, American Society for Microbiology. All Rights Reserved. In Vitro Activities of Daptomycin,
More informationAntimicrobial Prophylaxis in the Surgical Patient. M. J. Osgood
Antimicrobial Prophylaxis in the Surgical Patient M. J. Osgood Outline Definitions surgical site infection (SSI) Risk factors Wound classification Microbiology of SSIs Strategies for prevention of SSIs
More informationD-Lactic Acid Production as a Monitor of the Effectiveness
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Feb. 1991, p. 237-241 Vol. 35, No. 2 0066-4804/91/020237-05$02.00/0 Copyright 1991, American Society for Microbiology D-Lactic Acid Production as a Monitor of the
More informationInternational Journal of Advances in Pharmacy and Biotechnology Vol.3, Issue-2, 2017, 1-7 Research Article Open Access.
I J A P B International Journal of Advances in Pharmacy and Biotechnology Vol.3, Issue-2, 2017, 1-7 Research Article Open Access. ISSN: 2454-8375 COMPARISON OF ANTIMICROBIAL ACTIVITY AND MIC OF BRANDED
More informationConsiderations in antimicrobial prescribing Perspective: drug resistance
Considerations in antimicrobial prescribing Perspective: drug resistance Hasan MM When one compares the challenges clinicians faced a decade ago in prescribing antimicrobial agents with those of today,
More informationStanding Orders for the Treatment of Outpatient Peritonitis
Standing Orders for the Treatment of Outpatient Peritonitis 1. Definition of Peritonitis: a. Cloudy effluent. b. WBC > 100 cells/mm3 with >50% polymorphonuclear (PMN) cells with minimum 2 hour dwell. c.
More informationIntrinsic, implied and default resistance
Appendix A Intrinsic, implied and default resistance Magiorakos et al. [1] and CLSI [2] are our primary sources of information on intrinsic resistance. Sanford et al. [3] and Gilbert et al. [4] have been
More informationIntra-Abdominal Infections. Jessica Thompson, PharmD, BCPS (AQ-ID) Infectious Diseases Pharmacy Clinical Specialist Renown Health April 19, 2018
Intra-Abdominal Infections Jessica Thompson, PharmD, BCPS (AQ-ID) Infectious Diseases Pharmacy Clinical Specialist Renown Health April 19, 2018 Select guidelines Mazuski JE, et al. The Surgical Infection
More informationProceedings of the 13th International Congress of the World Equine Veterinary Association WEVA
www.ivis.org Proceedings of the 13th International Congress of the World Equine Veterinary Association WEVA October 3-5, 2013 Budapest, Hungary Reprinted in IVIS with the Permission of the WEVA Organizers
More informationby adding different antibiotics to sera containing
J. clin. Path., 1977, 30, 521-525 Serum gentamicin assays of 100 clinical serum samples by a rapid 40 C Kiebsiella method compared with overnight plate diffusion and acetyltransferase assays D. C. SHANSONI
More informationBurn Infection & Laboratory Diagnosis
Burn Infection & Laboratory Diagnosis Introduction Burns are one the most common forms of trauma. 2 million fires each years 1.2 million people with burn injuries 100000 hospitalization 5000 patients die
More informationChapter 51. Clinical Use of Antimicrobial Agents
Chapter 51 Clinical Use of Antimicrobial Agents History of antimicrobial therapy Early 17 th century Cinchona bark was used as an important historical remedy against malaria. 1909 Paul Ehrlich sought a
More informationPrinciples of Antimicrobial therapy
Principles of Antimicrobial therapy Laith Mohammed Abbas Al-Huseini M.B.Ch.B., M.Sc, M.Res, Ph.D Department of Pharmacology and Therapeutics Antimicrobial agents are chemical substances that can kill or
More informationIn Vitro Activity of Netilmicin, Gentamicin, and Amikacin
ANTIMICROBIAL AGzNTS AND CHEMOTHERAPY, Jan. 1977, p. 126-131 Copyright X 1977 American Society for Microbiology Vol. 11, No. 1 Printed in U.S.A. In Vitro Activity of Netilmicin, Gentamicin, and Amikacin
More informationUSA Product Label CLINTABS TABLETS. Virbac. brand of clindamycin hydrochloride tablets. ANADA # , Approved by FDA DESCRIPTION
VIRBAC CORPORATION USA Product Label http://www.vetdepot.com P.O. BOX 162059, FORT WORTH, TX, 76161 Telephone: 817-831-5030 Order Desk: 800-338-3659 Fax: 817-831-8327 Website: www.virbacvet.com CLINTABS
More informationDETERMINING CORRECT DOSING REGIMENS OF ANTIBIOTICS BASED ON THE THEIR BACTERICIDAL ACTIVITY*
44 DETERMINING CORRECT DOSING REGIMENS OF ANTIBIOTICS BASED ON THE THEIR BACTERICIDAL ACTIVITY* AUTHOR: Cecilia C. Maramba-Lazarte, MD, MScID University of the Philippines College of Medicine-Philippine
More informationAppropriate antimicrobial therapy in HAP: What does this mean?
Appropriate antimicrobial therapy in HAP: What does this mean? Jaehee Lee, M.D. Kyungpook National University Hospital, Korea KNUH since 1907 Presentation outline Empiric antimicrobial choice: right spectrum,
More informationClinical Policy: Clindamycin (Cleocin) Reference Number: CP.HNMC.08 Effective Date: Last Review Date: Line of Business: Medicaid - HNMC
Clinical Policy: (Cleocin) Reference Number: CP.HNMC.08 Effective Date: 07.01.17 Last Review Date: 02.18 Line of Business: Medicaid - HNMC Revision Log See Important Reminder at the end of this policy
More informationEuropean Committee on Antimicrobial Susceptibility Testing
European Committee on Antimicrobial Susceptibility Testing Routine and extended internal quality control as recommended by EUCAST Version 5.0, valid from 015-01-09 This document should be cited as "The
More informationResistance pattern of anaerobic bacteria isolated in a general hospital during a two-year period
Journal of Antimicrobial Chemotherapy (9), Supp. D, 9 6 Resistance pattern of anaerobic bacteria isolated in a general hospital during a two-year period J. F. Acar, F. W. Goldstein, M. D. Kitzis and M.
More informationQuantitative Study of Antibiotic-Induced Susceptibility to
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, July 199, p. 1348-1353 66-484/9/71348-6$2./ Copyright 199, American Society for Microbiology Vol. 34, No. 7 Quantitative Study of Antibiotic-Induced Susceptibility
More informationجداول میکروارگانیسم های بیماریزای اولویت دار و آنتی بیوتیک های تعیین شده برای آزمایش تعیین حساسیت ضد میکروبی در برنامه مهار مقاومت میکروبی
جداول میکروارگانیسم های بیماریزای اولویت دار و آنتی بیوتیک های تعیین شده برای آزمایش تعیین حساسیت ضد میکروبی در برنامه مهار مقاومت میکروبی ویرایش دوم بر اساس ed., 2017 CLSI M100 27 th تابستان ۶۹۳۱ تهیه
More informationStanding Orders for the Treatment of Outpatient Peritonitis
Standing Orders for the Treatment of Outpatient Peritonitis 1. Definition of Peritonitis: a. Cloudy effluent. b. WBC > 100 cells/mm3 with >50% polymorphonuclear (PMN) cells with minimum 2 hour dwell. c.
More informationAntimicrobial Selection and Therapy for Equine Musculoskeletal Trauma
Antimicrobial Selection and Therapy for Equine Musculoskeletal Trauma Lucio Petrizzi DVM DECVS Università degli Studi di Teramo Surgical site infections (SSI) Microbial contamination unavoidable Infection
More informationCase 2 Synergy satellite event: Good morning pharmacists! Case studies on antimicrobial resistance
Case 2 Synergy satellite event: Good morning pharmacists! Case studies on antimicrobial resistance 22nd Congress of the EAHP "Hospital pharmacists catalysts for change", 22-24 March 2017, Cannes Disclosure
More informationDetection and Quantitation of the Etiologic Agents of Ventilator Associated Pneumonia in Endotracheal Tube Aspirates From Patients in Iran
Letter to the Editor Detection and Quantitation of the Etiologic Agents of Ventilator Associated Pneumonia in Endotracheal Tube Aspirates From Patients in Iran Mohammad Rahbar, PhD; Massoud Hajia, PhD
More informationUnderstanding the Hospital Antibiogram
Understanding the Hospital Antibiogram Sharon Erdman, PharmD Clinical Professor Purdue University College of Pharmacy Infectious Diseases Clinical Pharmacist Eskenazi Health 5 Understanding the Hospital
More informationCiprofloxacin, Enoxacin, and Ofloxacin against Aerobic and
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Aug. 1988, p. 1143-1148 Vol., No. 8 0066-4804/88/081143-06$00/0 Copyright 1988, American Society for Microbiology Comparative Activities of, Amoxicillin-Clavulanic
More informationSee Important Reminder at the end of this policy for important regulatory and legal information.
Clinical Policy: Reference Number: CP.HNMC.24 Effective Date: 07.01.17 Last Review Date: 02.18 Line of Business: Medicaid - HNMC Revision Log See Important Reminder at the end of this policy for important
More informationChildrens Hospital Antibiogram for 2012 (Based on data from 2011)
Childrens Hospital Antibiogram for 2012 (Based on data from 2011) Prepared by: Department of Clinical Microbiology, Health Sciences Centre For further information contact: Andrew Walkty, MD, FRCPC Medical
More informationExperimental Pseudomonas Bacteremia in Neutropenic Rats
ANTIMICROBIAL AGENTs AND CHZMOTHERAPY, OCt. 1976, p. 646-651 Copyright C) 1976 American Society for Microbiology Vol. 10, No. 4 Printed in U.S.A. Synergistic Activity of Carbenicillin and Gentamicin in
More informationJAC Bactericidal index: a new way to assess quinolone bactericidal activity in vitro
Journal of Antimicrobial Chemotherapy (1997) 39, 713 717 JAC Bactericidal index: a new way to assess quinolone bactericidal activity in vitro Ian Morrissey* Department of Biosciences, Division of Biochemistry
More informationThe Basics: Using CLSI Antimicrobial Susceptibility Testing Standards
The Basics: Using CLSI Antimicrobial Susceptibility Testing Standards Janet A. Hindler, MCLS, MT(ASCP) UCLA Health System Los Angeles, California, USA jhindler@ucla.edu 1 Learning Objectives Describe information
More informationDiscrepancy Between Carbenicillin and Ampicillin Activities Against Enterococci and Listeria
ANTMCROBAL AGENTS AND CHEMOTHEAPY, Mar. 193, p. 3339 Copyright 193 American Society for Microbiology Vol. 3, No. 3 Printed in U.S.A. Discrepancy Between Carbenicillin and Ampicillin Activities Against
More informationAminoglycoside-resistant enterococci
Aminoglycoside-resistant enterococci M. J. BASKER, B. SLOCOMBE, AND R. SUTHERLAND From Beecham Pharmaceuticals Research Division, Brockham Park, Betchworth, Surrey J. clin. Path., 1977, 30, 375-380 SUMMARY
More informationDetermination of antibiotic sensitivities by the
Journal of Clinical Pathology, 1978, 31, 531-535 Determination of antibiotic sensitivities by the Sensititre system IAN PHILLIPS, CHRISTINE WARREN, AND PAMELA M. WATERWORTH From the Department of Microbiology,
More informationAberdeen Hospital. Antibiotic Susceptibility Patterns For Commonly Isolated Organisms For 2015
Aberdeen Hospital Antibiotic Susceptibility Patterns For Commonly Isolated s For 2015 Services Laboratory Microbiology Department Aberdeen Hospital Nova Scotia Health Authority 835 East River Road New
More informationAntibiotics in vitro : Which properties do we need to consider for optimizing our therapeutic choice?
Antibiotics in vitro : Which properties do we need to consider for optimizing our therapeutic choice? With the support of Wallonie-Bruxelles-International 1-1 In vitro evaluation of antibiotics : the antibiogram
More informationEDUCATIONAL COMMENTARY - Methicillin-Resistant Staphylococcus aureus: An Update
EDUCATIONAL COMMENTARY - Methicillin-Resistant Staphylococcus aureus: An Update Educational commentary is provided through our affiliation with the American Society for Clinical Pathology (ASCP). To obtain
More informationBackground and Plan of Analysis
ENTEROCOCCI Background and Plan of Analysis UR-11 (2017) was sent to API participants as a simulated urine culture for recognition of a significant pathogen colony count, to perform the identification
More informationDefining Resistance and Susceptibility: What S, I, and R Mean to You
Defining Resistance and Susceptibility: What S, I, and R Mean to You Michael D. Apley, DVM, PhD, DACVCP Department of Clinical Sciences College of Veterinary Medicine Kansas State University Susceptible
More informationPatients. Excludes paediatrics, neonates.
Full title of guideline Author Division & Speciality Scope Gentamicin Prescribing Guideline For Adult Patients Annette Clarkson, Specialist Clinical Pharmacist Antimicrobials and Infection Control All
More informationQuality Control Testing with the Disk Antibiotic Susceptibility Test of Bauer-Kirby-Sherris-Turck
Quality Control Testing with the Disk Antibiotic Susceptibility Test of Bauer-Kirby-Sherris-Turck DONNA J. BLAZEVIC, M.P.H., MARILYN H. KOEPCKE, B.S., A JOHN M. MATSEN, M.D. Departments of Laboratory Medicine
More informationThere are two international organisations that set up guidelines and interpretive breakpoints for bacteriology and susceptibility
ANTIMICROBIAL SUSCEPTIBILITY TESTING ON MILK SAMPLES Method and guidelines There are two international organisations that set up guidelines and interpretive breakpoints for bacteriology and susceptibility
More informationESBL Producers An Increasing Problem: An Overview Of An Underrated Threat
ESBL Producers An Increasing Problem: An Overview Of An Underrated Threat Hicham Ezzat Professor of Microbiology and Immunology Cairo University Introduction 1 Since the 1980s there have been dramatic
More informationPILOT STUDY OF THE ANTIMICROBIAL SUSCEPTIBILITY OF SHIGELLA IN NEW ZEALAND IN 1996
PILOT STUDY OF THE ANTIMICROBIAL SUSCEPTIBILITY OF SHIGELLA IN NEW ZEALAND IN 996 November 996 by Maggie Brett Antibiotic Reference Laboratory ESR Communicable Disease Centre Porirua CONTENTS Page SUMMARY
More information2017 Antibiogram. Central Zone. Alberta Health Services. including. Red Deer Regional Hospital. St. Mary s Hospital, Camrose
2017 Antibiogram Central Zone Alberta Health Services including Red Deer Regional Hospital St. Mary s Hospital, Camrose Introduction This antibiogram is a cumulative report of the antimicrobial susceptibility
More informationSusceptibility of the Bacteroides fragilis Group in the United
ANTIMICROBIAL AGENTS AND CHEMOTHERPY, Apr. 1983, p. 536-540 0066-4804/83/040536-05$02.0O/0 Copyright C 1983, American Society for Microbiology Vol. 23, No. 4 Susceptibility of the Bacteroides fragilis
More informationWho should read this document? 2. Key practice points 2. Background/ Scope/ Definitions 2. What is new in this version? 3
Neurosurgical infections (adult only) Antibiotic Guidelines Classification: Clinical Guideline Lead Author: Antibiotic Steering Committee Additional author(s): as above Authors Division: DCSS & Tertiary
More informationCombination antibiotic therapy: comparison of constant infusion and intermittent bolus dosing in an experimental animal model
Journal of Antimicrobial Chemotherapy (1985) 15, Suppl. A, 313-321 Combination antibiotic therapy: comparison of constant infusion and intermittent bolus dosing in an experimental animal model Joyce J.
More information2015 Antibiogram. Red Deer Regional Hospital. Central Zone. Alberta Health Services
2015 Antibiogram Red Deer Regional Hospital Central Zone Alberta Health Services Introduction. This antibiogram is a cumulative report of the antimicrobial susceptibility rates of common microbial pathogens
More informationBrief reports. Decreased susceptibility to imipenem among penicillin-resistant Streptococcus pneumoniae
Journal of Antimicrobial Chemotherapy (1997) 40, 105 108 Brief reports JAC Decreased susceptibility to imipenem among penicillin-resistant Streptococcus pneumoniae Andreas Pikis a *, Jacob A. Donkersloot
More informationEmpiric Treatment of Sepsis. Professor of Clinical Microbiology Department of Microbiology Leicester University U. K.
VOL. 38 NO. 8 CHEMO THERAPY Empiric Treatment of Sepsis Emmerson A M Professor of Clinical Microbiology Department of Microbiology Leicester University U. K. Empiric Treatment of Sepsis The treatment of
More informationDisk Susceptibility Studies with Cefazolin and Cephalothin
ANTIMICROBiAL AGENTS AND CHEMOTHEMRAPY, Jan. 1974, p. 63-67 Copyright i 1974 American Society for Microbiology Vol. 5, No. 1 Printed in U.SA. Disk Susceptibility Studies with Cefazolin and Cephalothin
More informationProtein Synthesis Inhibitors
Protein Synthesis Inhibitors Assistant Professor Dr. Naza M. Ali 11 Nov 2018 Lec 7 Aminoglycosides Are structurally related two amino sugars attached by glycosidic linkages. They are bactericidal Inhibitors
More informationTreatment of septic peritonitis
Vet Times The website for the veterinary profession https://www.vettimes.co.uk Treatment of septic peritonitis Author : Andrew Linklater Categories : Companion animal, Vets Date : November 2, 2016 Septic
More informationFactors affecting plate assay of gentamicin
Journal of Antimicrobial Chemotherapy (1977) 3, 17-23 Factors affecting plate assay of gentamicin II. Media D. C. Shanson* and C. J. Hince Department of Medical Microbiology, The London Hospital Medical
More informationcoverage. The purpose of this study was to compare the susceptibility of 297 strains of anaerobic and a new broad-spectrum semisynthetic
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Nov. 1978, p. 643-649 0066-4804/78/0014-0643$02.00/0 Copyright 1978 American Society for Microbiology Vol. 14, No. 5 Printed in U.S.A. Susceptibility of the Anaerobic
More informationAspects of the Chronic Toxicity of Gentamicin Sulfate in Cats
THE JOURNAL OF INFECTIOUS DISEASES VOL. 124, SUPPLEMENT DECEMBER 1971 1971 by the University of Chicago. All rights reserved. Aspects of the Chronic Toxicity of Gentamicin Sulfate in Cats J. Allan Wait,
More informationImpact of Spores on the Comparative Efficacies of Five Antibiotics. Pharmacodynamic Model
AAC Accepts, published online ahead of print on 12 December 2011 Antimicrob. Agents Chemother. doi:10.1128/aac.01109-10 Copyright 2011, American Society for Microbiology and/or the Listed Authors/Institutions.
More informationThe Pharmaceutical and Chemical Journal, 2018, 5(1): Research Article
, 2018, 5(1):145-152 Available online www.tpcj.org Research Article ISSN: 2349-7092 CODEN(USA): PCJHBA In Search of the Truth about the Quality of Mueller Hinton Agar and Tested Antimicrobial Discs Daniela
More informationCOMMITTEE FOR VETERINARY MEDICINAL PRODUCTS
The European Agency for the Evaluation of Medicinal Products Veterinary Medicines and Inspections EMEA/CVMP/627/01-FINAL COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS GUIDELINE FOR THE DEMONSTRATION OF EFFICACY
More informationIntroduction to Chemotherapeutic Agents. Munir Gharaibeh MD, PhD, MHPE School of Medicine, The university of Jordan November 2018
Introduction to Chemotherapeutic Agents Munir Gharaibeh MD, PhD, MHPE School of Medicine, The university of Jordan November 2018 Antimicrobial Agents Substances that kill bacteria without harming the host.
More information